Financials
- Market Capitalization 152.07 M
- Employee 152
- Founded 2013
- CEO N/A
- Website www.lenz-tx.com
- Headquarter Delaware, United States
- FIGI BBG00XDH4NZ2
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.61
Rapporto prezzo/fatturato
24.15
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3743 | NRXP NRX Pharmaceuticals, Inc. - Common Stock | 3.55 USD | -1.93% | +0.85% | +2.01% | +99.44% | 153.70 M USD | ||
| 3744 | INDP Indaptus Therapeutics, Inc. - Common Stock | 1.15 USD | -0.86% | -10.16% | -34.66% | -39.47% | 153.23 M USD | ||
| 3752 | EQ Equillium, Inc. - Common Stock | 2.40 USD | -2.04% | +3.90% | +5.73% | +33.33% | 152.18 M USD | ||
| 3756 | UNCY Unicycive Therapeutics, Inc. - Common Stock | 5.37 USD | -2.36% | -3.07% | +7.83% | -17.51% | 149.58 M USD |